JP2022541938A5 - - Google Patents
Info
- Publication number
- JP2022541938A5 JP2022541938A5 JP2022504655A JP2022504655A JP2022541938A5 JP 2022541938 A5 JP2022541938 A5 JP 2022541938A5 JP 2022504655 A JP2022504655 A JP 2022504655A JP 2022504655 A JP2022504655 A JP 2022504655A JP 2022541938 A5 JP2022541938 A5 JP 2022541938A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- formula
- less
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921029554 | 2019-07-22 | ||
| IN201921029554 | 2019-07-22 | ||
| PCT/IB2020/056914 WO2021014386A1 (en) | 2019-07-22 | 2020-07-22 | Selective estrogen receptor degrader |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541938A JP2022541938A (ja) | 2022-09-28 |
| JP2022541938A5 true JP2022541938A5 (https=) | 2023-08-02 |
Family
ID=71842730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504655A Pending JP2022541938A (ja) | 2019-07-22 | 2020-07-22 | 選択的エストロゲン受容体分解剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11014915B2 (https=) |
| EP (1) | EP4003525A1 (https=) |
| JP (1) | JP2022541938A (https=) |
| KR (1) | KR20220046586A (https=) |
| CN (1) | CN114302879A (https=) |
| AU (1) | AU2020317099A1 (https=) |
| BR (1) | BR112022001285A2 (https=) |
| CA (1) | CA3148592A1 (https=) |
| CL (1) | CL2022000156A1 (https=) |
| IL (1) | IL290036A (https=) |
| MX (1) | MX2022001013A (https=) |
| PE (1) | PE20221588A1 (https=) |
| PH (1) | PH12022550182A1 (https=) |
| WO (1) | WO2021014386A1 (https=) |
| ZA (1) | ZA202201157B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021003440A2 (pt) * | 2018-09-07 | 2021-05-18 | Sanofi | sais de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil) pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxilato de metila e seu processo de preparação |
| CN114127054B (zh) | 2019-07-22 | 2024-04-09 | 勃林格殷格翰国际有限公司 | 作为用于治疗炎性气道或纤维化疾病的自分泌运动因子(atx)调节剂的n-甲基、n-(6-(甲氧基)哒嗪-3-基)胺衍生物 |
| KR20220046586A (ko) * | 2019-07-22 | 2022-04-14 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 선택적 에스트로겐 수용체 분해제 |
| CA3243621A1 (en) * | 2022-02-01 | 2023-08-10 | Eli Lilly And Company | METHODS FOR PREPARING SELECTIVE ESTROGEN RECEPTOR DEGRADING AGENTS |
| CN119176799B (zh) * | 2024-09-19 | 2025-10-03 | 晨伫(杭州)生物科技有限责任公司 | 色烯衍生物及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395842A (en) | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| EP0470310B1 (en) | 1990-08-09 | 1995-11-29 | Council of Scientific and Industrial Research | Novel benzopyrans and process for their production |
| US6060503A (en) | 1991-12-02 | 2000-05-09 | Endorecherche, Inc. | Benzopyran-containing compounds and method for their use |
| US5407947A (en) | 1993-11-05 | 1995-04-18 | Eli Lilly And Company | Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans |
| US5389646A (en) | 1993-12-30 | 1995-02-14 | Zymogenetics, Inc. | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
| AU8102398A (en) | 1997-07-09 | 1999-02-08 | Central Drug Research Institute | (dl)-2,3-diaryl-2h-1-benzopyrans |
| DE10013782A1 (de) | 2000-03-15 | 2001-10-18 | Schering Ag | 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| RS56042B1 (sr) | 2010-06-10 | 2017-09-29 | Seragon Pharmaceuticals Inc | Modulatori estrogenih receptora i njihove upotrebe |
| WO2013090829A1 (en) | 2011-12-14 | 2013-06-20 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| EP2791128A4 (en) | 2011-12-16 | 2015-04-22 | Olema Pharmaceuticals Inc | NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF |
| CA2915534A1 (en) * | 2013-06-19 | 2014-12-24 | Seragon Pharmaceuticals, Inc. | Azetidine estrogen receptor modulators and uses thereof |
| WO2014203132A1 (en) | 2013-06-19 | 2014-12-24 | Olema Pharmaceuticals, Inc. | Substituted benzopyran compounds, compositions and uses thereof |
| EA031077B1 (ru) | 2013-06-19 | 2018-11-30 | Серагон Фармасьютикалз, Инк. | Модулятор рецептора эстрогена и его применения |
| CN103879283B (zh) * | 2014-03-10 | 2019-01-15 | 浙江吉利汽车研究院有限公司 | 一种电动车辆 |
| US20160175284A1 (en) * | 2014-12-18 | 2016-06-23 | Genentech, Inc. | Estrogen receptor modulators and uses thereof |
| WO2016174551A1 (en) | 2015-04-27 | 2016-11-03 | Pfizer Inc. | Anti-estrogenic compounds |
| US10053451B2 (en) | 2015-05-26 | 2018-08-21 | Genentech, Inc. | Heterocyclic estrogen receptor modulators and uses thereof |
| WO2017072792A1 (en) * | 2015-10-27 | 2017-05-04 | Sun Pharma Advanced Research Company Limited | Novel heterocyclic antiestrogens |
| KR20220046586A (ko) * | 2019-07-22 | 2022-04-14 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 선택적 에스트로겐 수용체 분해제 |
-
2020
- 2020-07-22 KR KR1020227005904A patent/KR20220046586A/ko not_active Ceased
- 2020-07-22 AU AU2020317099A patent/AU2020317099A1/en not_active Abandoned
- 2020-07-22 JP JP2022504655A patent/JP2022541938A/ja active Pending
- 2020-07-22 CN CN202080053315.6A patent/CN114302879A/zh active Pending
- 2020-07-22 US US16/936,022 patent/US11014915B2/en active Active
- 2020-07-22 WO PCT/IB2020/056914 patent/WO2021014386A1/en not_active Ceased
- 2020-07-22 EP EP20747136.8A patent/EP4003525A1/en not_active Withdrawn
- 2020-07-22 CA CA3148592A patent/CA3148592A1/en active Pending
- 2020-07-22 PE PE2022000135A patent/PE20221588A1/es unknown
- 2020-07-22 BR BR112022001285A patent/BR112022001285A2/pt not_active IP Right Cessation
- 2020-07-22 PH PH1/2022/550182A patent/PH12022550182A1/en unknown
- 2020-07-22 MX MX2022001013A patent/MX2022001013A/es unknown
-
2021
- 2021-05-05 US US17/308,501 patent/US20210261534A1/en not_active Abandoned
-
2022
- 2022-01-22 CL CL2022000156A patent/CL2022000156A1/es unknown
- 2022-01-23 IL IL290036A patent/IL290036A/en unknown
- 2022-01-25 ZA ZA2022/01157A patent/ZA202201157B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541938A5 (https=) | ||
| JP2013523733A5 (https=) | ||
| JP2022141835A5 (https=) | ||
| JP2022543155A5 (https=) | ||
| JP2024119812A5 (https=) | ||
| FI3897636T3 (fi) | Substituoituja 3-((3-aminofenyyli)amino)piperidiini-2,6-dioniyhdisteitä, niiden koostumuksia ja menetelmiä niillä annettavia hoitoja varten | |
| JP2019014758A5 (https=) | ||
| JP2009502743A5 (https=) | ||
| CN114072396A (zh) | 作为dna-pk抑制剂的喹啉和噌啉衍生物 | |
| JP2017530983A5 (https=) | ||
| JP2014502641A5 (https=) | ||
| HRP20160287T1 (hr) | Antagonisti cgrp receptora | |
| JP2020512337A5 (https=) | ||
| RU2010107892A (ru) | Производные феноксипирролидина, их применение и фармацевтические композиции, содержащие их | |
| JP2024520630A5 (https=) | ||
| JP2010501519A5 (https=) | ||
| EA016687B8 (ru) | Производные циклопропиламида | |
| JP2011509301A5 (https=) | ||
| JP2016522254A5 (https=) | ||
| JP2025504379A5 (https=) | ||
| JP2024523822A5 (https=) | ||
| JP2004525184A5 (https=) | ||
| JP2022539152A5 (https=) | ||
| JP2011509308A5 (https=) | ||
| JP2019529460A5 (https=) |